Soluble CD40 Ligand Levels in Children with Newly Diagnosed Graves’ Disease

Soluble CD40 Ligand Levels in Children with Newly Diagnosed Graves’ Disease

Objective:Soluble CD40 ligand (sCD40L) is elevated in various autoimmune disorders, which may have diagnostic and therapeutic implications. The aims of the current study were to evaluate serum sCD40L concentrations in children with newly diagnosed Graves’ disease (GD) and to correlate its levels wit...

Full description

Bibliographic Details
Main Authors:	Kotb Abbass Metwalley, Hekma Saad Farghaly, Duaa Mohammed Raafat, Asmaa Mohammed Ismail, Ghada Mohamed Saied
Format:	Article
Language:	English
Published:	Galenos Yayincilik 2020-06-01
Series:	JCRPE
Subjects:	graves’ disease soluble cd40 ligand (scd40l) thyroid hormone thyroid volume
Online Access:	http://www.jcrpe.org/archives/archive-detail/article-preview/soluble-cd40-ligand-levels-in-children-with-newly-/30876

Similar Items

Assessment of serum levels of soluble CD40L in Egyptian children and adolescents with type 1 diabetes mellitus: Relationship to microalbuminuria and glycemic control
by: Kotb Abbass Metwalley, et al.
Published: (2013-01-01)

Subclinical hypothyroidism in children: updates for pediatricians
by: Kotb Abbass Metwalley, et al.
Published: (2021-06-01)

The correlation of serum sCD40 and its ligand contents with renal injury in patients with preeclampsia
by: Zuo-Mei Shang, et al.
Published: (2017-04-01)

PROGNOSTIC VALUE OF SOLUBLE CD40 LIGAND AFTER LIVER TRANSPLANTATION IN CHILDREN WITH CONGENITAL AND HEREDITARY DISEASES OF HEPATOBILIARY SYSTEM
by: O. P. Shevchenko, et al.
Published: (2012-05-01)

Correlation between serum sCD40L and sCD40 levels with disease progression and plaque property change in patients with ACS
by: Fa-Bing Zhao, et al.
Published: (2017-03-01)

Relationship of serum soluble CD40 ligand and interleukin-18 levels in patients with cerebral infarction
by: Qing Zou, et al.
Published: (2016-07-01)

SFas and FasL in etiopathogenesis of autoimmune diseases of the thyroid gland and nodular forms of goiter
by: M. I. Sheremet, et al.
Published: (2015-12-01)

The relation between lead exposure and inflammation / endothelial dysfunction
by: Lutfiye Tutkun, et al.
Published: (2020-06-01)

COMPARATIVE ANALYSIS OF SOLUBLE OF CD40 LIGAND LEVELS IN HEART RECIPIENTS TREATED WITH CYCLOSPORINE A AND TACROLIMUS
by: O. P. Shevchenko, et al.
Published: (2012-05-01)

Levels of Thyroid Autoantibodies in Patients with Graves’ Disease and Graves’ Ophtalmopathy - Original Article
by: Mihail Boyanov, et al.
Published: (2010-09-01)

Persistently higher serum sCD40L levels are associated with outcome in septic patients
by: Yingjian Liang, et al.
Published: (2021-01-01)

Thyroid Ultrasonography in Differentiation between Graves’ Disease and Hashimoto’s Thyroiditis
by: Pishdad P., et al.
Published: (2017-03-01)

Frequency of thyroid nodules and thyroid cancer in thyroidectomized patients with Graves’ disease
by: Caglar Keskin, et al.
Published: (2019-01-01)

Clinical value of soluble CD40 ligand in coronary heart disease patients
by: O. P. Shevchenko, et al.
Published: (1970-01-01)

Hyperthyroidism and Graves' disease: Is an ultrasound examination needed?
by: Lakshminarayanan Varadhan, et al.
Published: (2016-01-01)

Correlation Between Serum C-Reactive Protein (CRP) and Soluble Cd40 Ligand (sCD40L) with Disease Activity by Modified Rodnan Skin Score (mRSS) in Systemic Sclerosis Patients in Indonesia
by: Widi Palupi Ayu Padmandani, et al.
Published: (2018-12-01)

Diyabetik Nefropatide SCUBE-1 ve sCD40L Seviyelerinin İncelenmesi
by: Hilal KARAKAŞ, et al.
Published: (2019-12-01)

Thyroid Malignancies In Patients With Graves’ Disease
by: Hasan Güçer
Published: (2016-09-01)

Riedel Thyroiditis in a Patient with Graves Disease
by: Doo Young Lee, et al.
Published: (2013-06-01)

Graves’ ophthalmopathy – thyroid eye disease
by: Dagna Siedlecka, et al.
Published: (2019-08-01)

Serum Soluble CD40 Ligand in Predicting Simple Appendicitis and Complicated Appendicitis at Different Time Points in Children
by: Wun-Yan Huang, et al.
Published: (2021-06-01)

Effects of selenium in patients with Graves’ disease treated with antithyroid drugs
by: Elena A. Shabalina, et al.
Published: (2017-06-01)

Clinical, Hormonal, and Ultrasound Characteristics of Patients with Newly Diagnosed Graves’ Disease And Different Thyroid Antibody Profiles
by: Mekova R., et al.
Published: (2019-05-01)

Advanced Age and Mild Thyrotoxicosis are Associated with Nodular Goiter in Graves Disease
by: Serkan Yener, et al.
Published: (2009-06-01)

Genetic Variation at 5'-UTR of CD40 Gene and Patients Characteristics: Associated with Relapse in Graves' Disease
by: Trisia Lusiana Amir, et al.
Published: (2017-01-01)

Effect of sCD40L Combined with Vinorelbine on Lung Adenocarcinoma Cell A549
by: Shan LIU, et al.
Published: (2010-07-01)

Evaluation of Quality of Life in the Brazilian Graves' Disease Population: Focus on Mild and Moderate Graves' Orbitopathy Patients
by: Danilo Villagelin, et al.
Published: (2019-04-01)

Treatment of ophthalmopathy in the course of Graves’ disease
by: Magdalena Woźniak, et al.
Published: (2019-09-01)

Association Between Soluble CD40 Ligand and Hypercholesterolemia in Children and Adolescents
by: Aynur Küçükçongar Yavaş, et al.
Published: (2017-03-01)

Establishment and Identification of Chinese Hamster Ovary Cell Lines with Stable Expression of Soluble CD40 Ligands
by: JIANG Hua-wei, et al.
Published: (2014-09-01)

Soluble CD40 Levels in Plasma Are Associated with Cardiovascular Disease and in Carotid Plaques with a Vulnerable Phenotype
by: Annelie Shami, et al.
Published: (2021-09-01)

Association between the No-Reflow Phenomenon and Soluble CD40 Ligand Level in Patients with Acute ST-Segment Elevation Myocardial Infarction
by: Mustafa Begenc Tascanov, et al.
Published: (2019-07-01)

Manifestations of thyroid disease post COVID-19 illness: Report of Hashimoto thyroiditis, Graves’ disease, and subacute thyroiditis
by: Karen Feghali, et al.
Published: (2021-12-01)

Soluble CD40L is associated with increased oxidative burst and neutrophil extracellular trap release in Behçet’s disease
by: Sandro Félix Perazzio, et al.
Published: (2017-10-01)

Precision Medicine in Graves’ Disease: CD40 Gene Variants Predict Clinical Response to an Anti-CD40 Monoclonal Antibody
by: Larissa C. Faustino, et al.
Published: (2021-06-01)

R-CHOP-Associated Graves’ Hyperthyroidism
by: Natalie Mora, et al.
Published: (2019-07-01)

A case of simultaneous occurrence of Graves′ disease and Hashimoto′s thyroiditis
by: Anirban Majumder, et al.
Published: (2012-01-01)

Serum Levels of Soluble CD40 Ligand and Neopterin in HIV Coinfected Asymptomatic and Symptomatic Visceral Leishmaniasis Patients
by: Wim Adriaensen, et al.
Published: (2018-12-01)

Graves' Disease and Diabetes Mellitus
by: M. Suttan Assin, et al.
Published: (2019-01-01)

Current Diagnosis and Management of Graves’ Disease
by: Imam Subekti, et al.
Published: (2018-06-01)